Turk Ilac ve SerumnayiIST:TRILC -2.48%61 EV-to-FCF is 7.97 as of Jul. 03, 2026, which is 62% above its 10-year median of 4.92. GuruFocus rates IST:TRILC with a GF Score™ of 61/100 and a GF Value™ of ₺3.60 (Possible Value Trap). The stock has 11 warning signs investors should review. Among 562 Drug Manufacturers companies, Turk Ilac ve Serumnayi ranks better than 82.21% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Turk Ilac ve Serumnayi's Enterprise Value is ₺3,958 Mil.
Turk Ilac ve Serumnayi's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was ₺497 Mil. Therefore, Turk Ilac ve Serumnayi's EV-to-FCF for today is 7.97.
The historical rank and industry rank for Turk Ilac ve Serumnayi's EV-to-FCF or its related term are showing as below:
IST:TRILC'
s EV-to-FCF Range Over the Past 10 Years
Min: -123.94 Med: 4.92 Max: 225.1
Current: 8.22
During the past 5 years, the highest EV-to-FCF of Turk Ilac ve Serumnayi was 225.10. The lowest was -123.94. And the median was 4.92.
IST:TRILC's EV-to-FCF is ranked better than 82.21% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.525
vs IST:TRILC: 8.22
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Turk Ilac ve Serumnayi (IST:TRILC) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Turk Ilac ve Serumnayi's PE Ratio (TTM) for today is calculated as:
Turk Ilac ve Serumnayi's share price for today is ₺1.18.
Turk Ilac ve Serumnayi's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺-0.437.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IST:TRILC vs ZTS, UTHR, VTRS: EV-to-FCF Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Turk Ilac ve Serumnayi EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Turk Ilac ve Serumnayi's EV-to-FCF falls into.
Turk Ilac ve Serumnayi's current Enterprise Value is ₺3,958 Mil.
Turk Ilac ve Serumnayi's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺497 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Turk Ilac ve Serumnayi (IST:TRILC) has a EV-to-FCF of 7.97 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Turk Ilac ve Serumnayi and its competitors. This is 62% above median its historical median of 4.92. According to the industry distribution chart, Turk Ilac ve Serumnayi ranks #100 out of 562 companies in the Drug Manufacturers industry, placing it in the top 17.8%.
Is Turk Ilac ve Serumnayi's EV-to-FCF too high?
Turk Ilac ve Serumnayi's current EV-to-FCF of 7.97 is 62% above median its 10-year median of 4.92. The Drug Manufacturers industry median EV-to-FCF is 20.53. Turk Ilac ve Serumnayi's value of 7.97 is 61.2% below this industry median. Based on the distribution chart, Turk Ilac ve Serumnayi ranks #100 out of 562 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Turk Ilac ve Serumnayi has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Turk Ilac ve Serumnayi's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Turk Ilac ve Serumnayi ranks #100 out of 562 companies for EV-to-FCF. This places Turk Ilac ve Serumnayi in the top 18% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 20.53. Turk Ilac ve Serumnayi's value of 7.97 is 61.2% below this benchmark. While the company's 10-year median is 4.92 vs. the industry median of 20.53, Turk Ilac ve Serumnayi has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.53, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Turk Ilac ve Serumnayi's current EV-to-FCF of 7.97 is 61.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Turk Ilac ve Serumnayi and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Turk Ilac ve Serumnayi's current EV-to-FCF is 7.97, which is 62% above median its own 10-year median of 4.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Turk Ilac ve Serumnayi stock overvalued right now?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi (IST:TRILC) is currently considered Possible Value Trap. The stock's GF Value™ is ₺3.60, compared to a current price of ₺1.18 — trading 67.2% below its estimated fair value. The current EV-to-FCF is 7.97, which is 62% above median its 10-year median of 4.92 and 61.2% below the Drug Manufacturers industry median of 20.53. Turk Ilac ve Serumnayi's overall GF Score™ is 61/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Turk Ilac ve Serumnayi (IST:TRILC), the current EV-to-FCF is 7.97 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Turk Ilac ve Serumnayi (IST:TRILC) Overvalued in 2026?
Based on GuruFocus' analysis, Turk Ilac ve Serumnayi stock appears to be undervalued.
The current stock price of ₺1.18 is trading 67.2% below its estimated GF Value™ of ₺3.60.
GuruFocus considers Turk Ilac ve Serumnayi to be Possible Value Trap.
Key valuation signals for IST:TRILC:
EV-to-FCF: 7.97 (62% above median its 10-year median of 4.92)
GF Value™: ₺3.60 vs. price of ₺1.18 (67.2% below fair value)
Industry Position: 61.2% below the Drug Manufacturers median (#100 of 562)
No single metric tells the full story. See the IST:TRILC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:TRILC has been successfully added to your 
